# A Study to Evaluate the Effect of Hepatic Insufficiency on the Pharmacokinetics (PK) of ACP-196

> **NCT04867941** · PHASE1 · COMPLETED · sponsor: **Acerta Pharma BV** · enrollment: 18 (actual)

## Conditions studied

- Hepatic Insufficiency

## Interventions

- **DRUG:** ACP-196

## Key facts

- **NCT ID:** NCT04867941
- **Lead sponsor:** Acerta Pharma BV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-21
- **Primary completion:** 2015-02-02
- **Final completion:** 2015-02-02
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2021-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04867941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04867941, "A Study to Evaluate the Effect of Hepatic Insufficiency on the Pharmacokinetics (PK) of ACP-196". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04867941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*